HER-2/neu Gene Amplification in Esophageal Adenocarcinoma and Its Influence on Survival

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

Manfred Hofmann, Di Shi, Reinhard Büttner et al. · Histopathology · 2008 · 1.2K citations

Medicine, Oncology, Fish Pathology +16

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIα gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab

Minna Tanner, Maija Hollmén, Teemu T. Junttila et al. · Annals of Oncology · 2005 · 664 citations

Medicine, Cancer Biology, Oncology +15

A Computer Method for Calculating Kendall's Tau with Ungrouped Data

William Knight · Journal of the American Statistical Association · 1966 · 312 citations

Computing, Biostatistics, Computer Science +2

HER2 Expression in Gastric Cancer: Rare, Heterogeneous and of No Prognostic Value – Conclusions from 924 Cases of Two Independent Series

Heike I. Grabsch, Shivan Sivakumar, Sally Gray et al. · Analytical Cellular Pathology · 2010 · 264 citations · Full text

Medicine, Oncology, Pathology +14